SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $1.65M invested in Sonnet BioTherapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$259K
2
+$106K
3
+$90.3K
4
Northern Trust
Northern Trust
Illinois
+$18K
5
UBS Group
UBS Group
Switzerland
+$15K

Top Sellers

1
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$734K
2
$465K
3
$138K
4
$106K
5
$76K
6
$26K
7
$21K
8
$19K
9
$19K
10
$18K
11
$13K
12
$7K
13
$4K
14
$1K
15
$1K
16
$1K